Healthcare Industry News: cardiac imaging
News Release - March 22, 2012
Toshiba’s Newest Ultrasound Systems Offer Breakthrough Imaging Technologies and Advanced Cardiac CapabilitiesToshiba to Highlight Aplio 500 and Aplio 300; Enhancements to Aplio Artida’s 3D Imaging Capabilities at ACC Annual Meeting
CHICAGO--(Healthcare Sales & Marketing Network)--Improving the ability to diagnose cardiac disease with advanced ultrasound imaging, Toshiba America Medical Systems, Inc. will showcase the newest additions to its ultrasound product line, AplioTM 500 and Aplio 300 at this year’s American College of Cardiology (ACC) annual meeting in Chicago, March 24 – 27, 2012 (Booth #6026). Toshiba will also introduce new enhancements to its Aplio ArtidaTM flagship cardiac ultrasound.
Toshiba’s Aplio 500 brings quantitative cardiac analysis bedside and is the system of choice for all 2D cardiac imaging needs. Aplio 500 features Toshiba’s Wall Motion Tracking technology, combined with superior ergonomics and a smaller footprint, making it easier to maneuver for greater patient access and improved workflow. Toshiba’s new high-end shared-service ultrasound system, Aplio 300, offers exceptional image quality in a versatile platform designed for routine ultrasound exams, including cardiac.
Aplio Artida’s new software version 3.0 offers improved 3D imaging and next-generation 3D Wall Motion Tracking software, which provide accurate and reproducible quantitative analysis of cardiac function. In addition, the Artida’s enhanced single-beat 3D acquisition allows physicians to obtain high-quality 3D images with detailed 3D Wall Motion Tracking analysis on a wider range of patients, including those with arrhythmias and shortness of breath.
“Aplio Artida’s 3D Wall Motion Tracking capability enables clinicians to assess live 3D volume images in one cardiac cycle, allowing physicians to get their clinical information faster, even on technically difficult patients,” said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba. “Combining the dedicated cardiac system, Aplio Artida, with the new Aplio 500 and 300 gives Toshiba a complete cardiac ultrasound portfolio for virtually any imaging need.”
About Toshiba America Medical Systems, Inc.
With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.
Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems; and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).
Source: Toshiba America Medical Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.